Search the Knowledge Hub Archive
RAPS Convergence 2026: Navigating Regulatory Change, Real-World Evidence and AI in MedTech
Our key takeaways from RAPS Convergence 2026 highlight the growing importance of PMCF, real-world evidence and robust study design in an evolving MedTech regulatory landscape
How to generate Real-World Data through Post Market Surveys
This infographic explores how Post Market Surveys can generate Real-World Data (RWD), including Post-Market Clinical Follow-up (PMCF) and Post-Market Performance Follow-up (PMPF), to support evidence needs across the medical device lifecycle.
Off-label? Don't panic: A strategic approach to real-world data
Webcast now available, featuring expert presenters Edward Nobrega, Principal Clinical Evaluation Scientist at Boston Scientific, Breda Kearney, Clinical Regulatory Lead at BSI, and Marcus Torr, Head of Post Market Surveys at Purdie Pascoe.
Real-World Data: The fuel behind modern clinical evidence, and why Post Market Surveys are a smart way to capture it
As regulators worldwide including the FDA and EU Notified Bodies place greater emphasis on RWD, the industry faces a familiar but intensified challenge: how to generate high-quality, device-specific evidence efficiently, reliably, and without escalating costs. That’s where Post-Market Surveys come in.